Hjem › Ulcerøs kolitt › Rhode Island
Kliniske studier for Ulcerøs kolitt i Rhode Island
11 studier for Ulcerøs kolitt søker deltakere på steder i Rhode Island.
Byer i Rhode Island
Offisiell studietekst (engelsk)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- University Gastroenterology - Providence - Staniford Street /ID# 280919, Providence
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- University Gastroenterology, Providence
RekruttererFase 4
Alder 18 til 80 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06581328A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 025, Providence
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-019, Providence
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07845487A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- University Gastroenterology, Providence
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- University Gastroenterology, Providence
RekruttererFase 3
Alder 18 til 70 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- University Gastroenterology - Providence - West River Street, Providence
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07186101A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- University Gastroenterology, Providence
RekruttererFase 4
Alder 18 til 65 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06095128An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- University Gastroenterology - GI Alliance - Site Number: 8400103, Providence
RekruttererFase 3
Alder 16 til 80 · Alle kjønn · Oppdatert 20. aug. 2026 · NCT07184996Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Gastroenterology Associates, Providence
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 7. aug. 2026 · NCT05230173A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Providence
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 12. mar. 2026 · NCT07113522Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.